Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression
Objective To investigate the rate of decline in forced vital capacity (FVC), and the effect of nintedanib on the rate of decline in FVC, in subjects with systemic sclerosis-associated interstitial lung disease (SSc-ILD) who had risk factors for rapid decline in FVC. - Methods The SENSCIS trial enrol...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
February 16, 2023
|
| In: |
RMD Open
Year: 2023, Jahrgang: 9, Pages: 1-6 |
| ISSN: | 2056-5933 |
| DOI: | 10.1136/rmdopen-2022-002859 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1136/rmdopen-2022-002859 Verlag, lizenzpflichtig, Volltext: https://rmdopen.bmj.com/content/9/1/e002859 
|
| Verfasserangaben: | Dinesh Khanna, Toby M. Maher, Elizabeth R. Volkmann, Yannick Allanore, Vanessa Smith, Shervin Assassi, Michael Kreuter, Anna-Maria Hoffmann-Vold, Masataka Kuwana, Christian Stock, Margarida Alves, Steven Sambevski, Christopher P. Denton |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 183987841X | ||
| 003 | DE-627 | ||
| 005 | 20230706215412.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230323s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/rmdopen-2022-002859 |2 doi | |
| 035 | |a (DE-627)183987841X | ||
| 035 | |a (DE-599)KXP183987841X | ||
| 035 | |a (OCoLC)1389530911 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Khanna, Dinesh |e VerfasserIn |0 (DE-588)1284203433 |0 (DE-627)1839880007 |4 aut | |
| 245 | 1 | 0 | |a Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression |c Dinesh Khanna, Toby M. Maher, Elizabeth R. Volkmann, Yannick Allanore, Vanessa Smith, Shervin Assassi, Michael Kreuter, Anna-Maria Hoffmann-Vold, Masataka Kuwana, Christian Stock, Margarida Alves, Steven Sambevski, Christopher P. Denton |
| 264 | 1 | |c February 16, 2023 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 23.03.2023 | ||
| 520 | |a Objective To investigate the rate of decline in forced vital capacity (FVC), and the effect of nintedanib on the rate of decline in FVC, in subjects with systemic sclerosis-associated interstitial lung disease (SSc-ILD) who had risk factors for rapid decline in FVC. - Methods The SENSCIS trial enrolled subjects with SSc and fibrotic ILD of ≥10% extent on high-resolution CT. The rate of decline in FVC over 52 weeks was analysed in all subjects and in those with early SSc (<18 months since first non-Raynaud symptom), elevated inflammatory markers (C reactive protein ≥6 mg/L and/or platelets ≥330×109/L) or significant skin fibrosis (modified Rodnan skin score (mRSS) 15-40 or mRSS ≥18) at baseline. - Results In the placebo group, the rate of decline in FVC was numerically greater in subjects with <18 months since first non-Raynaud symptom (−167.8 mL/year), elevated inflammatory markers (−100.7 mL/year), mRSS 15-40 (−121.7 mL/year) or mRSS ≥18 (−131.7 mL/year) than in all subjects (−93.3 mL/year). Nintedanib reduced the rate of FVC decline across subgroups, with a numerically greater effect in patients with these risk factors for rapid FVC decline. - Conclusion In the SENSCIS trial, subjects with SSc-ILD who had early SSc, elevated inflammatory markers or extensive skin fibrosis had a more rapid decline in FVC over 52 weeks than the overall trial population. Nintedanib had a numerically greater effect in patients with these risk factors for rapid ILD progression. | ||
| 650 | 4 | |a Autoimmune Diseases | |
| 650 | 4 | |a Pulmonary Fibrosis | |
| 650 | 4 | |a Scleroderma, Systemic | |
| 650 | 4 | |a Therapeutics | |
| 700 | 1 | |a Maher, Toby M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Volkmann, Elizabeth R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Allanore, Yannick |e VerfasserIn |4 aut | |
| 700 | 1 | |a Smith, Vanessa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Assassi, Shervin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kreuter, Michael |d 1972- |e VerfasserIn |0 (DE-588)122645995 |0 (DE-627)082066795 |0 (DE-576)293362742 |4 aut | |
| 700 | 1 | |a Hoffmann-Vold, Anna-Maria |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kuwana, Masataka |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stock, Christian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Alves, Margarida |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sambevski, Steven |e VerfasserIn |4 aut | |
| 700 | 1 | |a Denton, Christopher P. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t RMD Open |d London : BMJ Publishing Group, 2015 |g 9(2023) vom: Feb., Artikel-ID e002859, Seite 1-6 |h Online-Ressource |w (DE-627)819493627 |w (DE-600)2812592-7 |w (DE-576)427161614 |x 2056-5933 |7 nnas |a Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression |
| 773 | 1 | 8 | |g volume:9 |g year:2023 |g month:02 |g elocationid:e002859 |g pages:1-6 |g extent:6 |a Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression |
| 856 | 4 | 0 | |u https://doi.org/10.1136/rmdopen-2022-002859 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://rmdopen.bmj.com/content/9/1/e002859 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230323 | ||
| 993 | |a Article | ||
| 994 | |a 2023 | ||
| 998 | |g 122645995 |a Kreuter, Michael |m 122645995:Kreuter, Michael |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PK122645995 |e 950000PK122645995 |e 950900PK122645995 |e 50000PK122645995 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 7 | ||
| 999 | |a KXP-PPN183987841X |e 4295439339 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title_sort":"Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression","title":"Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression"}],"id":{"doi":["10.1136/rmdopen-2022-002859"],"eki":["183987841X"]},"name":{"displayForm":["Dinesh Khanna, Toby M. Maher, Elizabeth R. Volkmann, Yannick Allanore, Vanessa Smith, Shervin Assassi, Michael Kreuter, Anna-Maria Hoffmann-Vold, Masataka Kuwana, Christian Stock, Margarida Alves, Steven Sambevski, Christopher P. Denton"]},"physDesc":[{"extent":"6 S."}],"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"February 16, 2023"}],"relHost":[{"id":{"issn":["2056-5933"],"zdb":["2812592-7"],"eki":["819493627"]},"titleAlt":[{"title":"Rheumatic & musculoskeletal diseases"}],"note":["Gesehen am 17.08.20"],"part":{"volume":"9","pages":"1-6","year":"2023","extent":"6","text":"9(2023) vom: Feb., Artikel-ID e002859, Seite 1-6"},"recId":"819493627","pubHistory":["1.2015 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title":"RMD Open","title_sort":"RMD Open"}],"origin":[{"publisher":"BMJ Publishing Group","dateIssuedDisp":"2015-","publisherPlace":"London","dateIssuedKey":"2015"}],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progressionRMD Open","language":["eng"]}],"person":[{"family":"Khanna","role":"aut","roleDisplay":"VerfasserIn","given":"Dinesh","display":"Khanna, Dinesh"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Toby M.","display":"Maher, Toby M.","family":"Maher"},{"display":"Volkmann, Elizabeth R.","role":"aut","roleDisplay":"VerfasserIn","given":"Elizabeth R.","family":"Volkmann"},{"roleDisplay":"VerfasserIn","role":"aut","given":"Yannick","display":"Allanore, Yannick","family":"Allanore"},{"family":"Smith","display":"Smith, Vanessa","role":"aut","roleDisplay":"VerfasserIn","given":"Vanessa"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Shervin","display":"Assassi, Shervin","family":"Assassi"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Michael","display":"Kreuter, Michael","family":"Kreuter"},{"family":"Hoffmann-Vold","display":"Hoffmann-Vold, Anna-Maria","role":"aut","roleDisplay":"VerfasserIn","given":"Anna-Maria"},{"given":"Masataka","roleDisplay":"VerfasserIn","role":"aut","display":"Kuwana, Masataka","family":"Kuwana"},{"family":"Stock","given":"Christian","role":"aut","roleDisplay":"VerfasserIn","display":"Stock, Christian"},{"family":"Alves","display":"Alves, Margarida","roleDisplay":"VerfasserIn","role":"aut","given":"Margarida"},{"family":"Sambevski","roleDisplay":"VerfasserIn","role":"aut","given":"Steven","display":"Sambevski, Steven"},{"family":"Denton","display":"Denton, Christopher P.","given":"Christopher P.","role":"aut","roleDisplay":"VerfasserIn"}],"language":["eng"],"note":["Gesehen am 23.03.2023"],"recId":"183987841X","type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a KHANNADINEEFFECTOFNI1620 | ||